WTW has reported net income of $239m in the first quarter of 2025 (Q1 2025), a 23% increase from $194m in the same period of the previous year.  

The insurer’s diluted earnings per share were $2.33 in Q1 2025, up 27% from $1.83 a year ago.  

However, the sale of its TRANZACT business resulted in a decline in revenues, which fell 5% to $2.22bn in Q1 2025 from $2.34bn in the prior year. 

Adjusted EBITDA (earnings before interest, taxes, depreciation and amortisation) for the quarter ended 31 March 2025 was $532m, 3% lower than Q1 2024.  

Income from operations surged by 54% to $432m from $280m in Q1 2024. 

In the Health, Wealth & Career segment, the company’s revenue stood at $1.17bn for the quarter, marking a 13% decrease from Q1 2024. 

The Risk and Broking segment’s revenue increased 5% year-on-year, reaching $1.03bn.  

The Corporate Risk & Broking division reported organic revenue growth, attributed to increased new business activity and “strong” client retention on a global scale, while Insurance Consulting and Technology reported organic revenue growth owing to Consulting and Technology practices. 

During the quarter, WTW repurchased 607,221 of its outstanding shares at a cost of $200m.  

WTW CEO Carl Hess said: “We had a solid start to the year, delivering results in line with our expectations and making strong progress on our strategy to accelerate our performance, enhance our efficiency and optimise our portfolio. We are well-positioned to help our clients navigate economic uncertainty and highly focused on driving continued growth and margin expansion, and we are confident in our outlook. I am proud of our team’s dedication and look forward to achieving our strategic and financial goals together.”